Bioabsorbable Stents Market to Reach US$ 1.1 Bn by 2032, Reports Persistence Market Research

The bioabsorbable stents market is undergoing a remarkable transformation, driven by innovations in medical technology and growing demand for less invasive cardiovascular treatments. Bioabsorbable stents offer a unique advantage over traditional metallic stents, as they naturally dissolve over time, eliminating the need for long-term device permanence in the body. This ability to degrade within the body significantly reduces the risk of complications such as thrombosis and in-stent restenosis, making them an attractive option for treating coronary artery disease (CAD) and other vascular conditions.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/3827

Overview of the Market

The global bioabsorbable stents market was valued at approximately US$ 0.53 billion in 2025 and is projected to reach US$ 1.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period from 2025 to 2032. The market is driven by increasing demand for minimally invasive procedures and the growing prevalence of cardiovascular diseases. Bioabsorbable stents, which naturally dissolve after completing their job of supporting the artery, are gaining significant traction among healthcare providers and patients alike. This growth is further spurred by advancements in materials like biodegradable polymers and magnesium alloys.

Leading the market are innovations in next-generation bioresorbable materials that offer superior mechanical strength, better bio-compatibility, and faster degradation rates. These innovations are being adopted globally, with North America maintaining a dominant market share, primarily due to its well-established healthcare infrastructure and early adoption of cutting-edge medical technologies. Meanwhile, emerging markets in Asia-Pacific, such as China and India, are witnessing significant growth due to increased healthcare investments and rising cardiovascular disease burdens.

Key Highlights from the Report

➤ The global bioabsorbable stents market is projected to grow at a CAGR of 10.2% from 2025 to 2032.
➤ The coronary artery disease (CAD) segment is expected to dominate the market, accounting for 79% of the market share in 2025.
➤ Polymer-based bioabsorbable stents, particularly those made from PLLA, remain the market leaders in terms of adoption.
➤ Magnesium-based bioabsorbable stents are the fastest-growing segment due to superior mechanical strength and quicker absorption.
➤ North America leads the bioabsorbable stents market, with over 47% of the market share in 2025.
➤ Asia-Pacific is the fastest-growing region, driven by rising healthcare investments and growing cardiovascular disease rates.

Market Segmentation

The bioabsorbable stents market can be segmented based on product type, end-user, and geographical region.

Product Type

Bioabsorbable stents are primarily categorized into two main types: polymer-based and metal-based stents. Polymer-based bioabsorbable stents, mainly composed of poly-L-lactic acid (PLLA), hold a significant share in the market due to their early approval and widespread use in coronary artery disease (CAD) cases. These stents are typically used with drug-eluting coatings, which help prevent restenosis, making them popular for treating lesions in patients with high-risk profiles. However, the challenge lies in the thicker strut profiles of polymer stents, which can sometimes hinder radial strength and delay resorption.

On the other hand, metal-based bioabsorbable stents, particularly those made from magnesium and zinc alloys, are the fastest-growing segment. These alloys are prized for their superior mechanical strength, quicker degradation times, and thinner strut designs. As a result, magnesium and zinc-based stents are gaining traction, especially among younger, active patients who need temporary support. These stents degrade more quickly (in 6-12 months) compared to polymer-based stents, which makes them attractive for patients who want reduced long-term complications.

End-User Insights

By end-user, the bioabsorbable stents market is largely dominated by hospitals, which are expected to account for 49% of the total market share in 2025. Hospitals play a vital role in the treatment of CAD due to their access to advanced imaging systems like intravascular ultrasound (IVUS) and optical coherence tomography (OCT). These technologies help ensure precise stent placement and reduce procedural risks. Hospitals are the preferred choice for complex coronary interventions, as they are equipped with specialized catheterization labs and experienced interventional cardiologists.

On the other hand, Ambulatory Surgical Centers (ASCs) are expected to be the fastest-growing segment. The rise of outpatient procedures, combined with lower hospitalization costs and faster patient recovery times, is accelerating the adoption of bioabsorbable stents in ASCs. This trend is especially visible in regions like the U.S., Germany, and the U.K., where healthcare systems are becoming more value-driven and supporting outpatient procedures.

✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/bioabsorbable-stents-market.asp

Regional Insights

North America

North America holds the largest share of the bioabsorbable stents market, with the United States leading the way. In 2025, North America is projected to account for over 47% of the global market. The region benefits from an advanced healthcare infrastructure and high adoption rates of new medical technologies. In particular, the U.S. has been a hub for clinical trials such as ABSORB III and IV, which laid the groundwork for bioresorbable stent adoption. The prevalence of coronary artery disease (CAD) in the region also contributes to the demand for these innovative devices, with thousands of coronary interventions taking place annually.

Europe

Europe, particularly countries like Germany, France, and the U.K., remains at the forefront of bioabsorbable stent development. Germany is a key player in developing thinner strut designs and drug-coated polymer bioabsorbable stents, with promising clinical outcomes shown in the BIOSOLVE registry. The European Union has also invested heavily in research initiatives like Horizon Europe to promote the development of bioresorbable materials. Regulatory agencies like the U.K.'s National Health Service (NHS) are exploring hybrid stenting approaches to improve long-term patient outcomes, especially in younger STEMI patients.

Asia-Pacific

Asia-Pacific is emerging as the fastest-growing region in the bioabsorbable stents market. Countries like China and India are experiencing a rapid increase in cardiovascular disease cases, prompting a greater demand for interventional devices. In China, domestic companies like MicroPort Scientific are gaining approval for their bioabsorbable stents, while India's public-private health initiatives, such as Ayushman Bharat, are helping improve access to these life-saving devices. The rise of minimally invasive procedures and government support for heart disease treatment are key factors driving market growth in this region.

Market Drivers

One of the primary drivers of the bioabsorbable stents market is the increasing demand for minimally invasive procedures. As patients seek quicker recovery times and less invasive treatments, bioabsorbable stents offer a promising solution. Additionally, the rising prevalence of coronary artery disease (CAD) across both developed and emerging markets continues to boost demand for stenting procedures. Bioabsorbable stents, which gradually dissolve in the body, offer a significant advantage over traditional metallic stents, reducing the long-term risks associated with permanent implants.

Moreover, advancements in bioresorbable materials, particularly magnesium and zinc alloys, have expanded the clinical application of bioabsorbable stents. These materials provide better radial strength and faster resorption rates, making them ideal for younger, more active patients who require temporary vascular support. The growing focus on improving stent safety, coupled with innovations like AI-guided imaging for precision stent placement, is further accelerating market growth.

Market Restraints

Despite their many advantages, bioabsorbable stents face several challenges that could hinder market growth. One of the primary concerns is the limited stability of magnesium alloy stents. In some cases, magnesium alloys corrode too quickly, causing a loss of radial strength before the vessel has fully healed. This premature degradation can lead to complications such as inflammation, neointimal proliferation, and the formation of hydrogen gas, which can negatively impact patient outcomes.

Furthermore, polymer-based bioabsorbable stents, while effective, require thicker struts to ensure adequate radial strength. This can lead to vessel injury during deployment, increasing the risk of complications such as scaffold fracture and late thrombosis. These limitations are restricting the broader clinical adoption of bioabsorbable stents, particularly in patients with complex lesions.

Market Opportunities

The bioabsorbable stents market also presents several significant opportunities. One of the most promising developments is the rise of hybrid polymer-metal composite stents, which combine the strengths of both materials. These hybrid stents offer faster vessel healing, improved mechanical support, and controlled degradation, making them an ideal solution for a broader range of patients.

Another exciting opportunity lies in the integration of AI and robotic technology for stent placement. AI-driven hybrid stents, optimized for individual patients, are expected to revolutionize the stenting process by offering highly personalized solutions. Additionally, the use of robotic-assisted catheter deployment systems promises to enhance procedural precision and reduce complications, thereby increasing the appeal of bioabsorbable stents.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/3827

Reasons to Buy the Report

✔ Gain comprehensive insights into the global bioabsorbable stents market, including growth forecasts and key trends.
✔ Understand the key market drivers, restraints, and opportunities shaping the future of bioabsorbable stents.
✔ Analyze market segmentation by product type, end-user, and geography to identify the most lucrative opportunities.
✔ Stay updated on the latest developments in the bioabsorbable stents market, including technological innovations and new product launches.
✔ Access a detailed competitive landscape with profiles of leading companies and emerging players in the market.

Company Insights

✦ Biotronik SE & Co. KG
✦ Elixir Medical Corporation
✦ Arterius Ltd.
✦ Meril Life Sciences
✦ REVA Medical

Key Developments in the Market

In February 2025, Lepu Medical (China) received approval for its self-developed bioabsorbable coronary stent under China's priority review channel.

In May 2024, Abbott Laboratories confirmed its return to the bioresorbable space, with early-stage R&D on next-gen ultra-thin strut BVS platforms.

Conclusion

The bioabsorbable stents market is poised for significant growth, driven by technological innovations, an increasing prevalence of cardiovascular diseases, and the rising demand for minimally invasive procedures. The market is evolving rapidly, with advancements in bioresorbable materials like magnesium and zinc alloys offering enhanced mechanical strength, faster degradation, and reduced long-term risks compared to traditional stents. These innovations are likely to expand the clinical applications of bioabsorbable stents, making them a promising option for patients with coronary artery disease and other vascular conditions.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.